Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002523427 | SCV003440805 | pathogenic | not provided | 2021-12-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln476*) in the CNGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNGB3 are known to be pathogenic (PMID: 28795510). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of achromatopsia (PMID: 28341476, 28795510). ClinVar contains an entry for this variant (Variation ID: 427691). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000497367 | SCV005679209 | pathogenic | Achromatopsia 3 | 2024-05-29 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV000497367 | SCV000575835 | pathogenic | Achromatopsia 3 | 2017-03-27 | no assertion criteria provided | research |